Exiris makes use of several platform technologies for target identification and validation. In addition, Exiris is developing its own antibody and drug conjugate technologies: Cancer stem cell platform, Drug conjugate technology and Antibody ID technology.read more
Exiris provides contract research services and collaborative development agreements using its innovative technology platforms: CSC Platform, Target ID, Drug-Conjugate platform, Custom human mAb production, Biomarker discovery and (…)read more
Despite no open positions are currently available, feel free to apply here: Exiris will save your CV in a database that will be consulted when in search of new experienced and highly motivated collaborators.
Via Castel Romano 100
00128 Roma RM – Italy
Viale Carlo Felice 103
00185 Rome – Italy
+39 06 50576530